Acetylation of androgen receptor enhances coactivator binding and promotes prostate cancer cell growth.
about
A novel function of caspase-8 in the regulation of androgen-receptor-driven gene expressionThe cell fate determination factor dachshund inhibits androgen receptor signaling and prostate cancer cellular growthHormonal control of androgen receptor function through SIRT1Regulation of androgen receptor and histone deacetylase 1 by Mdm2-mediated ubiquitylationTherapeutic Rationales, Progresses, Failures, and Future Directions for Advanced Prostate CancerDichotomy in the Epigenetic Mark Lysine Acetylation is Critical for the Proliferation of Prostate Cancer CellsPathogenic mechanisms and therapeutic strategies in spinobulbar muscular atrophyMetastasis-associated protein 2 is a repressor of estrogen receptor alpha whose overexpression leads to estrogen-independent growth of human breast cancer cellsThe cell fate determination factor DACH1 is expressed in estrogen receptor-alpha-positive breast cancer and represses estrogen receptor-alpha signalingCyclin D1 represses p300 transactivation through a cyclin-dependent kinase-independent mechanismAn acetylation switch modulates the transcriptional activity of estrogen-related receptor alphaTargeted therapy for advanced prostate cancer: inhibition of the PI3K/Akt/mTOR pathwayCharacterisation of a Tip60 specific inhibitor, NU9056, in prostate cancerCell fate determination factor DACH1 inhibits c-Jun-induced contact-independent growthDisruption of a Sirt1-dependent autophagy checkpoint in the prostate results in prostatic intraepithelial neoplasia lesion formationAcetylation of androgen receptor by ARD1 promotes dissociation from HSP90 complex and prostate tumorigenesis.A phase 2 study of intravenous panobinostat in patients with castration-resistant prostate cancer.Minireview: The versatile roles of lysine deacetylases in steroid receptor signalinglncRNA-dependent mechanisms of androgen-receptor-regulated gene activation programs.The progesterone receptor hinge region regulates the kinetics of transcriptional responses through acetylation, phosphorylation, and nuclear retention.Coactivator MYST1 regulates nuclear factor-κB and androgen receptor functions during proliferation of prostate cancer cells.Intrinsic disorder in the androgen receptor: identification, characterisation and drugability.Distinctly different dynamics and kinetics of two steroid receptors at the same response elements in living cells.Pleiotropic effects of p300-mediated acetylation on p68 and p72 RNA helicase.The impact of point mutations in the human androgen receptor: classification of mutations on the basis of transcriptional activityControl of progesterone receptor transcriptional synergy by SUMOylation and deSUMOylation.Control of human PIRH2 protein stability: involvement of TIP60 and the proteosome.The androgen receptor acetylation site regulates cAMP and AKT but not ERK-induced activity.The chicken ovalbumin upstream promoter-transcription factor II negatively regulates the transactivation of androgen receptor in prostate cancer cells.Activation of p300 histone acetyltransferase activity and acetylation of the androgen receptor by bombesin in prostate cancer cells.Cell fate determination factor Dachshund reprograms breast cancer stem cell function.Lysine methylation and functional modulation of androgen receptor by Set9 methyltransferaseAcetylation and nuclear receptor actionAcetylation of estrogen receptor alpha by p300 at lysines 266 and 268 enhances the deoxyribonucleic acid binding and transactivation activities of the receptor.Loss of Sirt1 promotes prostatic intraepithelial neoplasia, reduces mitophagy, and delays PARK2 translocation to mitochondriap300 (histone acetyltransferase) biomarker predicts prostate cancer biochemical recurrence and correlates with changes in epithelia nuclear size and shape.Increased acetylation in the DNA-binding domain of TR4 nuclear receptor by the coregulator ARA55 leads to suppression of TR4 transactivationDifferential gene regulation by selective association of transcriptional coactivators and bZIP DNA-binding domainsHistone deacetylases are required for androgen receptor function in hormone-sensitive and castrate-resistant prostate cancer.Structural and functional analysis of domains of the progesterone receptor.
P2860
Q24336995-B917CAF1-50A8-4784-BD47-B3E167379473Q24658169-3095435F-AEFF-465A-B4F6-C079929F5CABQ24672448-1F10B2CB-FC71-46D6-99FD-6A1CFA50E246Q24793292-451CC7A1-2EFC-4B7C-ADDA-0A09AD6A9EBDQ26750620-D0323120-6A05-4E9D-AF91-73637E6220F3Q26795738-EEFDD03B-D7ED-4A66-818C-90C6DFBF4F83Q27007098-A53DCC49-2B99-4419-9D59-376073F9784BQ28237005-453C0FC1-43B7-42DD-AD08-2CE64C8D415FQ28252084-98DF7A59-E92D-4761-AA70-987E28489429Q28256059-C90B6DD8-E413-4190-B31B-BBDB397F2515Q28282893-7C417B67-AFD3-4F91-82F1-93B3DA8FB79DQ28382812-D5DBBE7F-2D3A-481F-A9DD-8441C95693D1Q28484264-9695DC20-DA3E-4907-9340-660B0FBAFDCAQ28507445-9B2760EC-A784-4498-99E7-0C1409C07D1CQ28588760-32F3B536-C6BC-4AB4-AA45-C999073392FCQ30353562-2EDA0947-BB1B-41BE-AA52-BDFD01867937Q33408846-217B32B2-C90D-4FBE-899E-50753B77C1C7Q33632070-E3291044-A82A-4F03-B306-D8E3DAA7A84DQ33666551-677BADEB-FE65-4827-A52E-9B1CFBA437F2Q33699615-77E9AB4C-0EDB-4BAF-9A2A-F648EF665447Q33701358-BEEDB76B-087A-427A-A333-44279CF8E7C2Q33984776-A3457EBE-24C6-4706-BE78-95DB089B433AQ34061900-1D972B05-4DD4-451E-A943-7A58AB55CD26Q34155238-5990E06A-DF8B-451B-8462-4E02C49824F5Q34189517-3933DB82-A9A0-4675-AED8-4AC44D0D0AD9Q34206915-4CAF7C4A-4A27-4C91-A795-86B132F4D9DAQ34287238-6315B163-E2CB-40E7-937A-574A36419007Q34318315-C18E7D02-D1FD-4C9E-BD88-B3887EE68C79Q34473887-0B2D3449-B59A-41CD-A167-71F1FFCE8DB1Q34487820-FBCF6CC4-3A75-412E-A70F-3BE4018487E0Q34503221-C1949B18-FF3C-4194-8305-DC44B4AB4624Q34609949-8CD3B96F-57A8-4DD3-BE6E-C0420413BF0DQ34666075-96E04576-2759-4E3C-BCF8-10DE9DC49157Q34698474-C3201D63-061E-465F-B7C2-FB1625B3BF9DQ34780856-66E98006-D52A-4534-A507-B6A92CFF6003Q34997026-49C10266-0914-4F1A-985C-0E5E6EB09BA2Q35065122-23A72528-3381-4EF3-B490-0EFBD25DFF1DQ35071079-1E646866-C622-40FB-ADEF-183D508C9FB5Q35559975-155B9983-6D2E-47B0-94A3-05159490CE71Q35624126-6E9BFFC2-1773-4B44-A38F-0D2141221E7E
P2860
Acetylation of androgen receptor enhances coactivator binding and promotes prostate cancer cell growth.
description
2003 nî lūn-bûn
@nan
2003 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Acetylation of androgen recept ...... s prostate cancer cell growth.
@ast
Acetylation of androgen recept ...... s prostate cancer cell growth.
@en
Acetylation of androgen recept ...... s prostate cancer cell growth.
@nl
type
label
Acetylation of androgen recept ...... s prostate cancer cell growth.
@ast
Acetylation of androgen recept ...... s prostate cancer cell growth.
@en
Acetylation of androgen recept ...... s prostate cancer cell growth.
@nl
prefLabel
Acetylation of androgen recept ...... s prostate cancer cell growth.
@ast
Acetylation of androgen recept ...... s prostate cancer cell growth.
@en
Acetylation of androgen recept ...... s prostate cancer cell growth.
@nl
P2093
P2860
P1476
Acetylation of androgen recept ...... s prostate cancer cell growth.
@en
P2093
Chawnshang Chang
Chenguang Wang
Chris Albanese
Dolores Di Vizio
Eliot Rosen
Jorma J Palvimo
Mahadev Rao
Maria Laura Avantaggiati
P2860
P304
P356
10.1128/MCB.23.23.8563-8575.2003
P407
P577
2003-12-01T00:00:00Z